KR100893779B1 - The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical - Google Patents
The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical Download PDFInfo
- Publication number
- KR100893779B1 KR100893779B1 KR1020070045441A KR20070045441A KR100893779B1 KR 100893779 B1 KR100893779 B1 KR 100893779B1 KR 1020070045441 A KR1020070045441 A KR 1020070045441A KR 20070045441 A KR20070045441 A KR 20070045441A KR 100893779 B1 KR100893779 B1 KR 100893779B1
- Authority
- KR
- South Korea
- Prior art keywords
- angelica
- extract
- ethanol
- free radical
- concentrate
- Prior art date
Links
- 240000001810 Angelica gigas Species 0.000 title claims abstract description 23
- 235000018865 Angelica gigas Nutrition 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title claims abstract description 15
- 150000003254 radicals Chemical class 0.000 title abstract description 10
- 230000000694 effects Effects 0.000 title description 3
- 230000002000 scavenging effect Effects 0.000 title description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 63
- 239000000284 extract Substances 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000012141 concentrate Substances 0.000 claims description 16
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000011346 highly viscous material Substances 0.000 claims description 2
- 239000002075 main ingredient Substances 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims 1
- 230000003381 solubilizing effect Effects 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 14
- 230000007760 free radical scavenging Effects 0.000 abstract description 8
- 239000003963 antioxidant agent Substances 0.000 abstract description 6
- 241000125175 Angelica Species 0.000 abstract description 5
- CUKSFECWKQBVED-INIZCTEOSA-N Decursin Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-INIZCTEOSA-N 0.000 abstract description 5
- CUKSFECWKQBVED-UHFFFAOYSA-N Grandivittin Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C=C(C)C)C(C)(C)OC1=C2 CUKSFECWKQBVED-UHFFFAOYSA-N 0.000 abstract description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 5
- JXZWWIMXTVJNSF-UHFFFAOYSA-N decursin Natural products CC(=CC(=O)OC1Oc2cc3OC(=O)C=Cc3cc2CC1(C)C)C JXZWWIMXTVJNSF-UHFFFAOYSA-N 0.000 abstract description 5
- 238000000746 purification Methods 0.000 abstract description 5
- AGABNGOXUSXQDD-XKGFZTIGSA-N [(3s)-2,2-dimethyl-8-oxo-3,4-dihydropyrano[3,2-g]chromen-3-yl] (z)-2-methylbut-2-enoate Chemical compound C1=CC(=O)OC2=C1C=C1C[C@H](OC(=O)C(\C)=C/C)C(C)(C)OC1=C2 AGABNGOXUSXQDD-XKGFZTIGSA-N 0.000 abstract description 4
- AGABNGOXUSXQDD-UHFFFAOYSA-N decursinol angelate Natural products C1=CC(=O)OC2=C1C=C1CC(OC(=O)C(C)=CC)C(C)(C)OC1=C2 AGABNGOXUSXQDD-UHFFFAOYSA-N 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 239000003610 charcoal Substances 0.000 abstract 1
- 235000014666 liquid concentrate Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229920002567 Chondroitin Polymers 0.000 description 2
- BGXFQDFSVDZUIW-UHFFFAOYSA-N Decursinol Natural products O1C(=O)C=CC2=C1C=C1OC(C)(C)C(O)CC1=C2 BGXFQDFSVDZUIW-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 2
- BGXFQDFSVDZUIW-LBPRGKRZSA-N decursinol Chemical compound O1C(=O)C=CC2=C1C=C1OC(C)(C)[C@@H](O)CC1=C2 BGXFQDFSVDZUIW-LBPRGKRZSA-N 0.000 description 2
- 231100001261 hazardous Toxicity 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 230000008836 DNA modification Effects 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- MDNQVRKYHGPJNA-UHFFFAOYSA-N Gigasol Natural products CC(C)(O)C(O)Cc1cc2C=CC(=O)Oc2c(COCc3c(O)c(CC(O)C(C)(C)O)cc4C=CC(=O)Oc34)c1O MDNQVRKYHGPJNA-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 240000006794 Volvariella volvacea Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000013014 purified material Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/02—Antioxidant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 유해 활성산소(free radical) 소거 효과가 있는 참당귀 추출물의 추출방법에 관한 것이다. The present invention relates to a method for extracting the Angelica gigas extract having a free radical scavenging effect.
유해 활성산소(free radical) 소거효과가 있는 참당귀 추출물은 그 주성분이 데커신과 데커시놀 안젤레이트가 90% 이상으로 구성된 액체 농축물이며, 본 발명은 참당귀 추출물은 인체에 투여 가능한 형태로 물과 에탄올로만 추출하였고, 또한 고 순도를 위하여 온도와 용해도 차이를 이용한 정제방법을 이용한 것이다. Charcoal Angelica extract with toxic free radical scavenging effect is a liquid concentrate composed of more than 90% of the major components of the decancin and decosinol angelate, the present invention is that the Angelica Angelica extract is in the form of water that can be administered to the human body Extracted only with and ethanol, and also using a purification method using the difference in temperature and solubility for high purity.
Angelica gigas Nakai, Decursin, Decursinol angelate, antioxidant, free radical Angelica gigas Nakai, Decursin, Decursinol angelate, antioxidant, free radical
Description
도1는 추출 정제된 96% 순도의 참당귀 추출 농축 정제물1 is an extract-purified concentrated purified Angelica gigas of 96% purity
도2은 참당귀(Angelica gigas Nakai)에서 추출 분리 정제한 데커시놀, 데커신 및 데커시놀 안젤레이트의 HPLC분석자료 및 구조 Figure 2 Angelica Angelica HPLC Analysis and Structure of Decosinol, Decosin and Decosinol Angelate Extracted and Purified from gigas Nakai)
참당귀는 한국이 원산지로서 그 사용 범위가 보혈제로서 한방약제로 이용되어져 왔으며 최근에는 한국산 지표물질인 데커신과 주요 성분인 데커시놀이 혈류개선 작용과 항 헬리코박터 작용이 있다고 보고되어 있으며 본 발명자 등이 밝힌 순수 정제된 데커신이 신장독성 억제와 당뇨합병증에 의한 신부전증의 예방 효과 및 당뇨성 고혈압에 효과가 있음을 동물실험을 통하여 밝힌 바 있다.Champagne Angelica has been used as a Korean medicine as a blood donor as a country of origin, and recently, it has been reported that Decacin, a Korean indicator, and Decacinol, a major ingredient, have blood flow improvement and anti-Helicobacter action, and the inventors have revealed pure water. It has been shown in animal experiments that purified decosin is effective in inhibiting kidney toxicity, preventing renal failure due to diabetic complications, and diabetic hypertension.
(PCT/ KR99 /00632). ( PCT / KR99 / 00632 ).
"강" 등이 밝힌 참당귀 추출물의 항산화 효과에 대한 연구결과가 발표되었는데 이 경우에는 열수 추출물을 사용한 추출물의 항산화 효과와 70%메탄올을 사용하여 3회추출하여 단순 농축하여 사용한 사례가 발표되어 있다. ( 한국식품영양과학회지, Vol.33, No.7, page 1112~1118, 2004년, 2004년 대한지역사회영양학회 춘계학술대회 poster 발표 ) A study on the antioxidant effect of Angelica gigas extract disclosed by "Kang" was published. In this case, the antioxidant effect of the extract using hot water extract and three times using 70% methanol were extracted and then concentrated. . (Korean Journal of Food and Nutrition Science, Vol. 33, No.7, page 1112 ~ 1118, 2004, 2004 Poster presented at the Korean Society of Community Nutrition Conference Spring Conference)
“강 ” 등의 연구결과는 열수 추출물 또는 70% 메탄올 추출물을 단순 농축하여 항산화 효과를 실험한 것으로 그 결과는 참당귀 열수 추출물 1mg/ml의 free radical 소거효과는 66.3%이며 , 70%메탄올 추출물 1mg/㎖의 소거효과는 81.5%로 보고되어 있으나 약효성분에 대한 분석결과는 표시되지 않았다. 즉 Decursin과 Decursinol angelate를 고 정제하여 실험한 것은 아니다. The research results of “Kang” and others were tested for the antioxidant effect by simply concentrating hot water extract or 70% methanol extract. The results showed that 1mg / ml of Cangdong Angelica hot water extract had a free radical scavenging effect of 66.3%, and 70% methanol extract 1mg. / Ml scavenging effect was reported as 81.5%, but the analysis results for the active ingredient was not shown. In other words, decursin and decursinol angelate were not highly purified and tested.
그리고 본 발명자는 기존의 방법보다 간편하고 추출량을 다량 확보할 수 있는 농축 방법을 확보하여 제조하였고 이것을 액제로 제조하여 실험동물에 경구적으로 투여 할 때 장관에서 용이하게 흡수되는 것을 확인 할 수 있었다. In addition, the inventors of the present invention prepared and secured a concentration method that is simpler than the existing method and secured a large amount of extraction, and it was confirmed that the solution was easily absorbed in the intestine when administered orally to the experimental animals.
데커신과 데커시놀 안젤레이트는 구조 이성질체로서 현재까지 잘 알려져 있지 않았으나 본 발명자 등이 그 작용을 연구하여 왔으며 그 분석법에 관한 것도 확립하여 밝힌바 있다.(한국특허 등록번호:0509843) Decusin and decosinol angelate have not been well known as structural isomers until now, but the present inventors have studied the action and have also established and analyzed the analysis method (Korean Patent Registration No .: 0509843).
데커신은 실온에서 고체로 존재할 수 있으나 데커시놀 안젤레이트는 영하 70도에서도 액체로 존재하며 참당귀에서는 데커신과 데커신놀 안젤레이트의 비율이 약 3 : 2정도 인 것으로 본 발명자 등이 이미 밝혔으며, 본 연구를 통하여 정제 후 Mass분석을 통한 정확한 함량 및 비율을 살펴본 결과 추출물(100%) 중 Decursin 50~54.5%, Decursinol angelate 40~42%, Decursinol 0.1~0.3%, 데커시놀 유도체 약 2~3%, 기타 1~2%로 구성된 정제물질을 확보하였다. Decasin may be present as a solid at room temperature, but decosinol angelate is present as a liquid even at minus 70 degrees, and in the Angelica gigas, the ratio of decosinol to decansinol angelate is about 3: 2. After purifying through this study, the exact content and ratio through mass analysis showed that Decursin 50 ~ 54.5%, Decursinol angelate 40 ~ 42%, Decursinol 0.1 ~ 0.3%, Decosinol derivatives about 2-3 Purified material consisting of% and other 1-2% was secured.
이런 결과는 기존의 데커신과 데커시놀 안젤레이트의 비율이 60대 40 즉 3 : 2의 비율과 약간의 차이를 보이는 평균 57 : 43 비율을 나타내었다. 또한 데커신류의 함량은 90%이상으로 기대이상의 결과를 도출하였다. 기존의 알콜 추출방법이나 70%알콜 추출방법으로는 참당귀에 존재하는 데커신의 함량이 추출 농축액의 35%내외인 것으로 알려져 왔고 그 양이 50%를 넘지 않았지만 본 연구자의 결과로서 99%이상의 주정 알콜 및 약전 에탄올을 사용하였을 때 그 농축된 함유량이 높게 나와 최대 75% 이상 88%까지 함유하는 결과를 도출한 바 있다. (한국특허 등록번호:0509843) These results indicated that the ratio of Deckersin and Dekersinol Angelate was 57:43, which was slightly different from that of 60 to 40, that is, 3: 2. In addition, the content of deckerin was above 90%, which resulted in more than expected results. The existing alcohol extraction method or 70% alcohol extraction method has been known that the content of decusin present in Angelica gigas is about 35% of the extract concentrate and the amount is not more than 50%, but as a result of this study, more than 99% alcohol alcohol And when the pharmacopeia ethanol was used, the concentrated content was high, resulting in containing up to 75% or more and 88%. (Korean patent registration number: 0509843)
본 연구는 기존방법을 개선하여 온도와 용해도 차이를 이용하여 순도를 높이는 방법을 개발하고자 하였다. This study aims to develop a method to improve the purity by using the difference of temperature and solubility by improving the existing method.
본 발명은 유해 활성산소(free radical) 소거에 탁월한 효과가 있는 데커신 및 데커시놀 안젤레이트를 유효성분으로 하는 참당귀추출물을 의약품이나 식품에 직접 사용할 수 있는 실용성이 있는 에탄올을 이용하여 순도 90%이상의 고 순도물로서 데커신 및 데커시놀 안젤레이트를 함유하는 참당귀 추출농축물을 생산하는 방법을 제공하는 것에 그 목적이 있다. The present invention provides purity 90 using practical ethanol, which can be used directly in medicine or foods, as the active extract of Angelica gigas extract, which is an active ingredient of decusin and decosinol angelate, which has an excellent effect on eliminating harmful free radicals. It is an object of the present invention to provide a method for producing a Angelica gigas extract concentrate containing decansin and decosinol angelate as high purity of more than%.
상기와 같은 목적을 달성하기 위하여 본 발명은 이미 개발된 정제법을 개선하여, 이번에 개발된 정제법은 주성분함량이 90%이상을 가질 수 있도록 에탄올과 물 그리고 온도, 용해도를 이용하여 참당귀 추출농축물을 생산하는 것을 특징으로 하며, 또한 본발명은 이렇게 해서 생산된 참당귀 추출농축물이 유해 활성산소(free radical) 소거에 탁월한 효능을 가지며 안정성면에서 우수한 항산화제(anti oxidant)로서 이용하는 것을 특징으로 한다. In order to achieve the above object, the present invention improves the purification method already developed, and this time the purification method developed by using ethanol and water and temperature, solubility so that the main component content can be more than 90% The present invention is characterized by producing water, and the present invention is characterized in that the extract extracted from Angelica gigas extract has excellent efficacy in eliminating harmful free radicals and is used as an excellent anti oxidant in terms of stability. It is done.
. .
기존의 정제방법으로는 90% 이상의 정제를 위해서는 유기용매 등을 사용해야하는데 유기용매는 잔류성이나 독성 및 역한 냄새가 존재하나 이번에 개발된 방법은 이런 문제를 발생시키지 않는 간단하면서도 경제적인 방법이며 정제 후 식품용이나 의약품용으로 직접 사용가능하다. 참당귀 추출 농축 정제 혼합물인 데커신 및 데커시놀 안젤레이트와의 병용 사용에 의해 효과적으로 유해 활성산소(free radical)을 제거할 수 있을 것으로 판단된다. Conventional purification methods require the use of organic solvents for the purification of more than 90%. Organic solvents have residual, toxic, and adverse odors, but the developed method is a simple and economical method that does not cause this problem. Can be used directly for medicine or medicine. It is considered that the free radicals can be effectively removed by the combined use of decansin and decosinol angelate, which is a concentrated extract mixture of Angelica gigas.
본 발명에서 주장하는 것은 의약품이나 식품에 직접 사용할 수 있는 실용성이 있는 에탄올을 이용하여 순도 90%이상의 고 순도물로서 데커신 및 데커시놀 안젤레이트를 함유하는 복합물을 제조하여 이용하는 것이다. 또한 데커신 및 데커시놀 안젤레이트를 유효성분으로 하는 참당귀추출물을 이용하여 항산화효과 등이 탁월하고 안전성면에서도 우수하여 항산화제(anti oxidant)로 사용하고자 한다. It is claimed in the present invention to prepare and use a complex containing deckercin and decosinol angelate as a high purity product having a purity of 90% or more using practical ethanol which can be used directly in medicine or food. In addition, by using the Angelica Angelica extract as the active ingredient of decusin and decosinol angelate, the antioxidant effect is excellent and safety is intended to be used as an antioxidant (anti oxidant).
일반적으로 한국산 참당귀 (Angelica gigas Nakai)의 주요 성분인 데커신 (decursin), 데커시놀 안젤레이트 (decursinol angelate), 데커시놀 (decursinol), 및/ 또는 이들을 2종 이상 포함하는 당귀추출물의 효과에 대하여는 많은 연구가 있어 왔는데, 참당귀 (Angelica gigas Nakai)로부터의 추출물은 전통적으로 빈혈치료, 진정제, 진통제 등으로 사용되어져 왔다.(D.J. Jung, A. Porzel, S. Huneck, Gigasol and other coumarins from Angelica gigas. Phytochemistry, 30, 710-712, 1991) Common Korean Angelica Angelica Much research has been conducted on the effects of decursin, decursinol angelate, decursinol, and / or two or more of the main components of gigas Nakai. , Angelica ( Angelica Extracts from gigas Nakai have traditionally been used to treat anemia, sedatives, painkillers, etc. (DJ Jung, A. Porzel, S. Huneck, Gigasol and other coumarins from Angelica gigas.Phytochemistry, 30, 710-712, 1991 )
큐마린 유도체인 데커신과 데커시놀 안젤레이트의 다양한 생리활성이 보고되고 있음에도 불구하고 이들의 체내동태에 대한 정보가 부족한 이유는 보다 순수하게 분리 정제하는 기술이 보유되지 않았고, 혈중에서의 정량법의 개발이 어려웠기 때문이라 사료된다. Despite the fact that various biological activities of the decursin and decosinol angelate derivatives have been reported, the lack of information on their physiological dynamics has not been achieved through the technology of purely separating and purifying them. This is because it was difficult.
세포내에서 발생하는 유해 활성산소(free radical)가 지질, 단백질, 핵산 등의 생체 분자들을 변화시켜 노화현상을 초래한다. 이러한 유해 활성산소(free radical)는 정상적인 대사과정에서도 소량 생성되며, 흡연, 세균감염, 공해, 질병상태나 과도한 스트레스, 자외선 노출 시 과잉으로 생성될 수 있다. 이렇게 체내에서 과잉으로 생성된 유해 활성산소(free radical)는 생체의 항산화방어 메카니즘을 깨트려 지질과산화, DNA 변형, 병리 생리학적인 이상상태를 초래한다. 따라서 이러한 항산화 메카니즘을 견고히 하는 것은 결국 건강을 유지하고 노화를 지연시킨다고 볼 수 있다. Hazardous free radicals generated in cells change the biomolecules such as lipids, proteins, and nucleic acids, leading to aging. These harmful free radicals are produced in small amounts in normal metabolic processes, and can be produced excessively during smoking, bacterial infections, pollution, disease or excessive stress, and UV exposure. The excess free radicals produced in the body break down the antioxidant defense mechanisms of the living body, resulting in lipid peroxidation, DNA modification, and pathological physiological abnormalities. Therefore, solidifying these antioxidant mechanisms can be said to maintain health and delay aging.
본 발명에서 실시한 참당귀 추출농축물의 유해 활성산소(free radical) 소거작용을 조사하였다. 그 결과 참당귀 추출농축물은 1,1-디페닐-2-피크릴히드라질(1,1-diphenyl-2-picrylhydrazyl) 에탄올 농도의 50%를 감소시키는데 필요한 시료농도 (SC50)가 0.047 중량%정도였고 이것은 항산화 효과가 뛰어나다고 알려진 상황버섯 추출물(특허 등록공고 제10-0206538호)의 SC50 값이 0.23 중량%인 것과 chondroitin (Purity 90%) (특허 등록공고 제 10-0365242)의 SC50 값이 0.56 중량%인 것과 약콩 사포닌 (특허 등록공고 제 10-0566857)의 SC50 값이 약 0.34 중량%인 것과 비교해 매우 우수한 것으로 나타났다. 따라서 본 발명의 결과로 참당귀 추출농축물의 항산화 효과는 다른 어떤 물질보다도 우수하였다. The free radical scavenging effect of the extract of Angelica gigas extract was carried out. As a result, the Angelica gigas extract concentrate had a sample concentration (SC 50 ) of 0.047 weight that was required to reduce 50% of the ethanol concentration of 1,1-diphenyl-2-picrylhydrazyl. It was about%, which means that SC 50 value of S. mushroom extract (Patent No. 10-0206538) is known to be excellent in antioxidant effect and 0.23% by weight of SC 50 and SC of chondroitin (Purity 90%) (Patent No. 10-0365242) It was found to be very good compared to the 50 value of 0.56% by weight and the SC 50 value of the soybean saponin (Patent Publication 10-0566857) about 0.34% by weight. Therefore, as a result of the present invention, the antioxidant effect of the extract of Angelica gigas extract was superior to any other substances.
(( 실시예Example ))
이하, 본 발명의 실제 실험 예를 상세히 설명한다.Hereinafter, the actual experimental example of the present invention will be described in detail.
이하의 실험 예에서는 참당귀로부터 주성분 데커신 및 데커시놀 안젤레이트를 90%이상 더욱 바람직하게는 95%이상 함유토록 하는 추출방법에 관한 것과 이 추출물을 이용하여 항산화 활성에 대한 시험결과를 예시한 것이다. The following experimental example relates to an extraction method containing 90% or more, more preferably 95% or more, of the main components of decancin and decosinol angelate from Angelica gigas and illustrates the results of the antioxidant activity using the extract. will be.
[[ 실시예Example 1] One] 데커신의Decker 용해도 산출 Solubility output
순수하게 합성 정제된 데커신을 이용하여 용해도를 산출하였다. 데커신 100 mg을 60% 에탄올 10㎖에 투입 후 잘 섞어주고 녹지 않은 물질을 10,000 rpm에서 1분간 원심분리하여 침전시키고 상등액을 제거한 후 침전한 물질의 양을 계산하였다. 100 mg에서 침전된 양을 빼주어 계산한 결과로서의 용해도가 6.6 mg/㎖ (60% 에탄올)임을 밝혔다. 또한 같은 방법으로 산출한 100% 에탄올에서의 용해도가 약 4,870 ㎎/㎖ 내외임을 밝혔다. 이 특성을 이용하여 재결정에 사용하여 순도를 높이는데 이용하였다. Solubility was calculated using purely synthetic purified decusin. 100 mg of decusin was added to 10 ml of 60% ethanol, mixed well, and the undissolved material was precipitated by centrifugation at 10,000 rpm for 1 minute, the supernatant was removed, and the amount of precipitated material was calculated. The solubility as a result of subtracting the amount precipitated from 100 mg was found to be 6.6 mg / mL (60% ethanol). In addition, the solubility in 100% ethanol calculated by the same method was about 4,870 mg / ml. It is said to be internal and external. This property was used for recrystallization to increase the purity.
[[ 실시예Example 2] 고 함유 2] high content 농축물Concentrate 제조 방법 Manufacturing method
참당귀로부터 데커신 및 데커시놀 안젤레이트를 분리 농축하는 방법으로서 한국산 및 북한산 당귀인 참당귀를 이용하여 실시하였다. 중국 원산지, 일본 원산지, 베트남 원산지의 경우에는 함량이 적어 경제적으로 가치가 없다.As a method of separating and concentrating Decusin and Decusinol Angelate from Angelica gigas, it was carried out using Korean Angelica gigas, Korean Angelica gigas. Originating in China, originating in Japan, and originating in Vietnam are of low content and are not economically valuable.
식품용 및 의약용으로 사용키 위하여 추출 용매는 약전 에탄올 및 주정 알콜을 사용하였고 물을 사용할 때는 정제수를 사용하였다. 원료인 참당귀를 40메시 (40 mesh)이하로 잘게 분쇄하여 수분함량 5% 이하로 건조하고 약전용 알콜 또는 주정알콜 (이하 ‘에탄올’로 표기)로 분쇄 참당귀의 2배에서 4배를 첨가하여 12시간이상 충분히 추출하였고 이것을 여과하여 정량하였다. 이 경우에는 농축물에 함유된 데커신과 데커시놀 안젤레이트의 함량이 33% 이었다. For the food and medicinal purposes, the extraction solvent was ethanol and alcohol alcohol, and purified water was used when using water. Grind the raw Angelica Angelica to less than 40 mesh (40 mesh), dry it to 5% or less of moisture, and add 2 to 4 times the amount of Angelica Angelica pulverized with medicinal alcohol or alcohol (hereinafter referred to as 'ethanol'). After 12 hours, the extract was sufficiently extracted and filtered. In this case, the content of decusin and decosinol angelate in the concentrate was 33%.
이 농축물을 증발 건고하여 점성이 높은 물질을 얻었다. 이 물질 1 킬로그람당 에탄올 1리터를 넣어 주성분을 녹이고 영하 20도에서 10시간 방치하여 생성된 침전물을 원심분리하여 제거 후 상등액을 얻었다. 상등액을 증발건고하여 농축물을 얻었다.This concentrate was evaporated to dryness to obtain a highly viscous material. 1 liter of ethanol per kilogram of this substance was dissolved to dissolve the main component, and the resulting precipitate was left at 20 ° C for 10 hours to remove the precipitate, which was then centrifuged to obtain a supernatant. The supernatant was evaporated to dryness to give a concentrate.
이 농축물에 60% 에탄올(희석 에탄올) 50 리터을 넣어 용출하였다. 이 경우에 농축물에 함유된 데커신과 데커시놀 안젤레이트는 330그람으로 60% 에탄올 50 리터에 녹을 수 있는 주성분의 량 또한 330 그람인 것을 이용하였다. 50 liters of 60% ethanol (diluted ethanol) was added to this concentrate and eluted. In this case, the concentrations of Decusin and Decusinol Angelate contained in the concentrate were 330 grams and the amount of the main component that could be dissolved in 50 liters of 60% ethanol was also used.
용출 후 원심분리하여 60% 에탄올 층만을 얻었다. 이것을 증발건고하여 농축물을 얻을 수 있었다. 이것을 99% 알코올에 녹여 상등액을 취하여 최종 농축물을 얻었다. (도1참조)After elution, centrifugation gave only a 60% ethanol layer. This was evaporated to dryness to give a concentrate. This was dissolved in 99% alcohol and the supernatant was taken to give the final concentrate. (See Fig. 1)
이것을 액체크로마토그램 (HPLC)으로 분석한 대표적인 결과는 다음과 같으며 함량은 데커신 54.52%, 데커시놀 안젤레이트 41.26%, 데커시놀 0.299%로 총 함량은 96%를 보였고 데커신 유도체가 2.5%를 보였다. 확정시험은 Mass spectrophotometer를 이용하여 분자량으로 하였다. 각각의 분자량은 MW 328.35, MW 328.35, MW 246.25 이었다. (도2 참조) Representative results of the liquid chromatography (HPLC) are as follows, the content of decosin 54.52%, decosinol angelate 41.26%, decosinol 0.299%, the total content was 96% and the decosin derivative 2.5 Showed%. Confirmation test was carried out using a mass spectrophotometer as the molecular weight. Each molecular weight was MW 328.35, MW 328.35, MW 246.25. (See Figure 2)
[실시예 3] 유해 활성산소(free radical) 소거 효과Example 3 Hazardous Free Radical Scavenging Effect
실시예 2에서 추출 정제한 참당귀 추출물을 이용하였다. 즉 96%의 순도를 갖는 데커신, 데커시놀 안젤레이트, 데커시놀을 주성분으로 하는 참당귀 추출물을 이용하였다. 유해 활성산소 소거 작용효과를 관찰한 것이다. The chaff extract extracted from Example 2 was used. In other words, the extract of Angelica gigas was used as a main component of the decansin, decosinol angelate, decosinol having a purity of 96%. Toxic free radical scavenging effect was observed.
0.2 mM 1,1-디페닐-2-피크릴히드라질(1,1-diphenyl-2-picrylhydrazyl) ethanol용액 0.5 ㎖ 에 에탄올을 용매로 하여 조제한 여러 농도의 시료를 1 ㎖ 넣 고 37℃에서 30분간 방치 후 517 nm에서 흡광도를 측정하였다. 그 결과, 유해 활성산소(free radical) 소거능력과 유해 활성산소(free radical)을 50% 감소시키는 농도 (SC50)은 아래식과 같이 구하였다. (시료의 유해 활성산소(free radical) 소거능력은 유해 활성산소 소거활성(scavenging activity, SC50)으로 표시할 수 있으며, 여기서 SC50은 DPPH(1,1-diphenyl-2-picrylhydrazyl)의 농도가 50% 감소하는데 필요한 시료의 농도로 나타난다)To 0.5 ml of 0.2 mM 1,1-diphenyl-2-picrylhydrazyl ethanol solution, 1 ml of various concentrations prepared by using ethanol as a solvent, Absorbance was measured at 517 nm after standing for a minute. As a result, the concentration (SC 50 ) that reduces the harmful free radicals and the free radicals by 50% was calculated as follows. (Free radical scavenging ability of the sample can be expressed as scavenging activity (SC 50 ), where SC 50 is the concentration of DPPH (1,1-diphenyl-2-picrylhydrazyl) Results in a concentration of sample required to decrease by 50%)
본 실시예에서 SC50은 0.047중량% 로 나타났다 (표1). SC50의 수치는 DPPH Inhibition ratio (%) 의 값이 50%를 보이는 지점을 의미한다.In this Example, SC 50 was found to be 0.047 wt% (Table 1) . The value of SC 50 means the point where the value of DPPH Inhibition ratio (%) shows 50%.
이것은 항산화 효과가 뛰어나다고 알려진 상황버섯 추출물(특허 등록공고 제10-0206538호)의 SC50 값이 0.23 중량%인 것과 chondroitin (Purity 90%) (특허 등록공고 제 10-0365242)의 SC50 값이 0.56 중량%인 것과 약콩 사포닌 (특허 등록공고 제 10-0566857)의 SC50 값이 약 0.34 중량%인 것과 비교해 매우 우수한 것으로 나타났다. 따라서 본 발명의 결과로 참당귀 추출농축물의 항산화 효과는 다른 어떤 물질보다도 우수하였다. This is the SC 50 the value of the antioxidant effect is excellent and known linteus extract SC 50 value is 0.23% by weight as chondroitin (Purity 90%) (Patent Registration Publication No. 10-0365242 of the Patent Registration No. 10-0206538 Bulletin) It was found to be very good compared to 0.56% by weight and the SC 50 value of the weak bean saponin (Patent Publication 10-0566857) was about 0.34% by weight. Therefore, as a result of the present invention, the antioxidant effect of the extract of Angelica gigas extract was superior to any other substances.
<표 1>TABLE 1
* DPPH(1,1-diphenyl-2-picrylhydrazyl) Inhibition ratio (%) DPPH (1,1-diphenyl-2-picrylhydrazyl) Inhibition ratio (%)
= [1- (E -B)/ C] x 100 = [1- (E -B) / C] x 100
. B (Blank) - EtOH 0.5 ㎖ + test sample 1 ㎖ . B (Blank)-0.5 ml of EtOH + 1 ml of test sample
. C (Control) - 0.2 mM DPPH 0.5 ㎖ + solvent 1 ㎖ . C (Control)-0.5 ml of 0.2 mM DPPH + 1 ml of solvent
. E( Experimental) - 0.2 mM DPPH 0.5 ㎖ + test sample 1 ㎖ . E (Experimental)-0.5 ml of 0.2 mM DPPH + 1 ml of test sample
이상 상기 실시예를 통하여 명백히 알 수 있는 바와 같이, 본 발명이 제공하는 참당귀(Angelica gigas Nakai)에서 정제된 농축물은 고순도 정제물로서 에탄올과 물만을 사용한 정제법으로 의약품 또는 식품으로 개발할 때 매우 유용한 것이며, 고순도의 데커신과 데커시놀 안젤레이트를 주성분으로 함유토록하기 위하여 온 도에 따른 용해도의 차이 및 에탄올과 물의 혼합비율에 따르는 용해도 차이를 이용하여 고 순도 물질을 얻었다. 참당귀(Angelica gigas Nakai)에서 정제된 농축물( 데커신, 데커시놀 안젤레이트 , 데커시놀 )은 유해 활성산소(free radical) 소거작용을 통한 항산화제(anti oxidant)로서 산업상 이용이 가능한 유용한 발명이 될 것이다. As can be clearly seen through the above embodiment, Angelica Angelica provided by the present invention ( Angelica The concentrate purified from gigas Nakai) is a high-purity refinement using only ethanol and water, which is very useful when developing into pharmaceuticals or foods, and contains high purity decansin and decusinol angelate as main ingredients. High purity material was obtained using the difference in solubility and the difference in solubility according to the mixing ratio of ethanol and water. Angelica Angelica Concentrates purified from gigas Nakai (deckerin, decosinol angelate, decosinol) have become useful inventions that can be used industrially as anti-oxidants through toxic free radical scavenging. will be.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070045441A KR100893779B1 (en) | 2007-05-10 | 2007-05-10 | The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070045441A KR100893779B1 (en) | 2007-05-10 | 2007-05-10 | The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080099636A KR20080099636A (en) | 2008-11-13 |
KR100893779B1 true KR100893779B1 (en) | 2009-04-20 |
Family
ID=40286577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070045441A KR100893779B1 (en) | 2007-05-10 | 2007-05-10 | The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100893779B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101233967B1 (en) * | 2010-11-26 | 2013-02-18 | 경성대학교 산학협력단 | Makgealli comprising decursine and/or decursinol angelate and manufacturing method thereof |
KR20160096883A (en) | 2015-02-06 | 2016-08-17 | 경성대학교 산학협력단 | Pharmaceutical Composition For Treating Hyperlipidaemia |
KR20210150829A (en) | 2020-06-04 | 2021-12-13 | 경성대학교 산학협력단 | Composition for treating of rhinitis comprising Angelica gigas extracts and indirubin |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010080265A (en) * | 1998-10-22 | 2001-08-22 | 정세영 | Pharmaceutical composition containing decursin |
KR100509843B1 (en) * | 2003-03-14 | 2005-08-24 | 주식회사 바이넥스 | Method of extraction decursin and decursinol angelate from Angelica gigas, Nakai |
KR20050089786A (en) * | 2005-08-27 | 2005-09-08 | 김형환 | Blood vessel relaxational agent containing decursin or decursinol angelate |
-
2007
- 2007-05-10 KR KR1020070045441A patent/KR100893779B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010080265A (en) * | 1998-10-22 | 2001-08-22 | 정세영 | Pharmaceutical composition containing decursin |
KR100509843B1 (en) * | 2003-03-14 | 2005-08-24 | 주식회사 바이넥스 | Method of extraction decursin and decursinol angelate from Angelica gigas, Nakai |
KR20050089786A (en) * | 2005-08-27 | 2005-09-08 | 김형환 | Blood vessel relaxational agent containing decursin or decursinol angelate |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101233967B1 (en) * | 2010-11-26 | 2013-02-18 | 경성대학교 산학협력단 | Makgealli comprising decursine and/or decursinol angelate and manufacturing method thereof |
KR20160096883A (en) | 2015-02-06 | 2016-08-17 | 경성대학교 산학협력단 | Pharmaceutical Composition For Treating Hyperlipidaemia |
KR20210150829A (en) | 2020-06-04 | 2021-12-13 | 경성대학교 산학협력단 | Composition for treating of rhinitis comprising Angelica gigas extracts and indirubin |
Also Published As
Publication number | Publication date |
---|---|
KR20080099636A (en) | 2008-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20160151440A1 (en) | A Novel Composition of Curcumin with Enhanced Bioavailability | |
AU2012338742B2 (en) | Composition comprising chicory extract | |
RU2426552C2 (en) | Extracts of phaseolus vulgaris, their application and compositions containing them | |
CN111249338A (en) | Cistanche deserticola extract and industrial preparation method and application thereof | |
KR100509843B1 (en) | Method of extraction decursin and decursinol angelate from Angelica gigas, Nakai | |
RU2322091C1 (en) | Composition of biologically active substances and method for preparing its nanodispersion | |
KR100893779B1 (en) | The extracting method of Angelica gigas Nakai that has effect of scavenging action on free radical | |
Riasat et al. | Scrutinizing the therapeutic response of Phyllanthus exmblica's different doses to restore the immunomodulation potential in immunosuppressed female albino rats. | |
CN104739917B (en) | The purposes of plant extract and preparation treatment hepatic fibrosis-renal tubular ectasia syndrome and the drug of liver cancer | |
KR100414187B1 (en) | Hepatoprotective extract derived from Protaetia brevitarsis and its use | |
CN103181930B (en) | Fructus Schisandrae Chinensis effective part of bee pollen form and the application in prevention hepar damnification thereof | |
Campuzano-Bublitz et al. | Acute and chronic anti-hyperglycemic effect of Prosopis ruscifolia extract in normoglycemic and alloxan-induced hyperglycemic rats | |
KR101144715B1 (en) | The oral medication for increasing of sperm numbers | |
Sènou et al. | Efficacy of ethyl acetate fraction of Cocos nucifera aqueous extract on the treatment of anemia | |
Ziaul Amin et al. | Evaluation of medicinal effects of Gynuraprocumbens leave extracts on oxidative, glycemic, lipidomics, and enzymatic profiles in alloxan-induced diabetic mice | |
RU2665968C1 (en) | Method for obtaining an agent of choleretic, anti-inflammatory and antioxidant activity | |
TWI618540B (en) | Composition for preventing renal toxicity caused by drug toxicity, preparation method thereof and Its use | |
Fernand et al. | Evaluation of antihyperglycemic, antiradical and acute oral toxicity activities of aqueous leaves extract of Moringa oleifera Lam (Moringaceae) from Benin in normal rats | |
RU2404789C2 (en) | Method for production of biologically active extract from pallas milkwort root | |
Amah et al. | Hematological evaluation of aqueous and methanolic leaf extracts of Thaumatococcus daniellii and Alchornea cordifolia in Wistar rats | |
Aldhafiri et al. | Hepatoprotective studies of methanolic leaf extract of Barringtonia acutangula (L) against carbon tetrachloride induced liver injury in wistar rats | |
Rahman et al. | Anti-Inflammatory and Analgesic Activities of Ethanolic Extract of Glochidion Thomsonii (BARK) | |
Kumar | Membrane Stabilizing and antioxidant activities of extracts from leaves of Elaeocarpus sphaericus | |
Sarkar et al. | Study of hypoglycemic activity of aqueous extract of Leucas indica Linn. aerial parts on streptozotocin induced diabetic rats | |
Alfarajat et al. | Reno-protective effect of Citrus sinensis by regulating antioxidant capability and gene expression in adenine-induced chronic kidney in rats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130319 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140108 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160203 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170411 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180405 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190409 Year of fee payment: 11 |